The Pennant Group (NASDAQ:PNTG) Rating Increased to Strong-Buy at Zacks Research

Zacks Research upgraded shares of The Pennant Group (NASDAQ:PNTG) from a hold rating to a strong-buy rating in a report released on Thursday,Zacks.com reports.

A number of other equities analysts have also weighed in on the stock. Weiss Ratings restated a “hold (c)” rating on shares of The Pennant Group in a research report on Monday. Stephens restated an “overweight” rating and issued a $40.00 price target on shares of The Pennant Group in a research report on Thursday, October 9th. Wall Street Zen downgraded The Pennant Group from a “buy” rating to a “hold” rating in a research report on Sunday, November 16th. Royal Bank Of Canada boosted their price objective on The Pennant Group from $34.00 to $39.00 and gave the stock an “outperform” rating in a research note on Monday, November 17th. Finally, Wells Fargo & Company upgraded The Pennant Group from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $29.00 to $31.00 in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $33.60.

The Pennant Group Stock Performance

NASDAQ PNTG opened at $26.67 on Thursday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The stock’s 50 day simple moving average is $24.95 and its 200-day simple moving average is $25.80. The company has a market cap of $922.52 million, a PE ratio of 35.56, a price-to-earnings-growth ratio of 2.10 and a beta of 1.39. The Pennant Group has a 1-year low of $21.18 and a 1-year high of $32.00.

The Pennant Group (NASDAQ:PNTG) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.29 by $0.01. The firm had revenue of $229.04 million during the quarter, compared to analysts’ expectations of $221.96 million. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. As a group, equities research analysts anticipate that The Pennant Group will post 0.75 EPS for the current fiscal year.

Institutional Investors Weigh In On The Pennant Group

A number of institutional investors and hedge funds have recently made changes to their positions in PNTG. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of The Pennant Group during the first quarter worth $428,000. Van Berkom & Associates Inc. boosted its holdings in The Pennant Group by 29.6% during the 1st quarter. Van Berkom & Associates Inc. now owns 2,849,562 shares of the company’s stock valued at $71,666,000 after acquiring an additional 651,346 shares during the period. Mackenzie Financial Corp grew its position in The Pennant Group by 25.2% in the 1st quarter. Mackenzie Financial Corp now owns 22,446 shares of the company’s stock valued at $565,000 after acquiring an additional 4,522 shares in the last quarter. Premier Fund Managers Ltd acquired a new stake in shares of The Pennant Group during the first quarter worth about $535,000. Finally, De Lisle Partners LLP boosted its stake in shares of The Pennant Group by 6.9% in the first quarter. De Lisle Partners LLP now owns 407,801 shares of the company’s stock valued at $10,260,000 after purchasing an additional 26,339 shares during the period. 85.88% of the stock is owned by hedge funds and other institutional investors.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.